Innoviva

(NASDAQ) INVA

Current Price$22.76

Market Cap$1.67B

Since IPO (2004)+66%

5 Year+92%

1 Year+20%

1 Month-2%

Innoviva Financials at a Glance

Market Cap

$1.67B

Revenue (TTM)

$424.12M

Net Income (TTM)

$504.34M

EPS (TTM)

$3.06

P/E Ratio

7.37

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Price

$22.76

Volume

46,731

Open

$23.49

Price

$22.76

Volume

46,731

Open

$23.49

Previous Close

$22.76

Daily Range

$22.23 - $23.88

52-Week Range

$16.52 - $25.14

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Price

$22.76

Volume

46,731

Open

$23.49

Previous Close

$22.76

Daily Range

$22.23 - $23.88

52-Week Range

$16.52 - $25.14

INVA News

Page 1

INVA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Innoviva

Industry

Pharmaceuticals

Sector

Health Care

Employees

159

CEO

Pavel Raifeld, CFA, MBA

Website

www.inva.com

Headquarters

Burlingame, CA 94010, US

INVA Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

15%

Net Income Margin

Return on Equity

29%

Return on Capital

Return on Assets

27%

Earnings Yield

13.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.67B

Shares Outstanding

74.07M

Volume

46.73K

Avg. Volume

726.46K

Financials (TTM)

Gross Profit

$307.52M

Operating Income

$163.75M

EBITDA

$383.79M

Operating Cash Flow

$196.93M

Capital Expenditure

$1.13M

Free Cash Flow

$195.80M

Cash & ST Invst.

$550.94M

Total Debt

$269.02M

Innoviva Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$97.99M

+10.6%

Gross Profit

$75.83M

-5.0%

Gross Margin

77.39%

N/A

Market Cap

$1.67B

N/A

Market Cap/Employee

$13.13M

N/A

Employees

127

N/A

Net Income

$186.59M

+500.6%

EBITDA

$38.15M

+239.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$344.99M

+7983.7%

Accounts Receivable

$0.00

-100.0%

Inventory

$38.84M

-6.4%

Long Term Debt

$258.10M

+0.1%

Short Term Debt

$0.00

-100.0%

Return on Assets

27.46%

N/A

Return on Invested Capital

3.55%

N/A

Free Cash Flow

$35.28M

-27.4%

Operating Cash Flow

$35.28M

-27.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NKTRNektar Therapeutics

NKTRNektar Therapeutics$83.37-2.02%

INBXInhibrx Biosciences, Inc.

INBXInhibrx Biosciences, Inc.$124.52-12.21%

SNDXSyndax Pharmaceuticals, Inc.

SNDXSyndax Pharmaceuticals, Inc.$20.54-0.53%

IMTXImmatics N.V.

IMTXImmatics N.V.$11.14-3.21%

CVACCureVac N.V.

CVACCureVac N.V.$4.66+0.00%

RLAYRelay Therapeutics, Inc.

RLAYRelay Therapeutics, Inc.$12.51-3.17%

ELVNEnliven Therapeutics, Inc.

ELVNEnliven Therapeutics, Inc.$40.29-2.21%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

ONDSOndas

ONDSOndas$8.89-0.05%

Questions About INVA

What is the current price of Innoviva?

Innoviva is trading at $22.76 per share.

What is the 52-week range for Innoviva?

Over the past 52 weeks, Innoviva has traded between $16.52 and $25.15.

How much debt does Innoviva have?

As of the most recent reporting period, Innoviva reported total debt of $331.42M.

How much cash does Innoviva have on hand?

Innoviva reported $603.09M in cash and cash equivalents in its most recent financial results.

What is Innoviva’s dividend yield?

Innoviva does not currently have a dividend yield.

Innoviva

Innoviva Financials at a Glance

INVA News

Innoviva (INVA) Q2 Sales Jump 64%

3 Small-Cap Stocks With Big-Cap Potential

2 Best Biotech Stocks to Buy in August

2 Incredibly Cheap Biotech Stocks

3 Top Biotech Stocks to Buy in April

3 Under-the-Radar Value Stocks to Buy in 2019

13 of the Cheapest Healthcare Stocks

3 Top Healthcare Stocks to Buy in June

INVA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Innoviva

INVA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Innoviva Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INVA

What is the current price of Innoviva?

What is the 52-week range for Innoviva?

How much debt does Innoviva have?

How much cash does Innoviva have on hand?

What is Innoviva’s dividend yield?

Premium Investing Services